TX-WEA
27.10.2021 10:34:07 CEST | Business Wire | Press release
The Women’s Entrepreneurship Accelerator (WEA), a strategic multi-partnership convening five UN agencies and Mary Kay Inc., is today joining forces with the Commonwealth Businesswomen’s Network (CBWN) to empower and support underserved women entrepreneurs across the 54 countries of the Commonwealth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211027005291/en/
WEA is designed to maximize the development impact of women entrepreneurship in achieving the Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs that fosters growth, sustainability, and resilience. In June 2021, WEA joined the Generation Equality Forum in Paris and committed to empower five million women around the world by 2030 to accelerate progress for gender equality.
WEA recently announced the launch of a series of impactful initiatives and knowledge products, all shaped through a gender lens, as the joint outcome of the collaboration between the International Labour Organization (ILO), the International Trade Centre (ITC), UN Global Compact (UNGC), UN Development Programme (UNDP) and UN Women with the strategic support and funding of Mary Kay. WEA’s impact work includes digital capacity building tools and training; entrepreneurship research; and gender-responsive procurement (GRP) advocacy and training.
CBWN works with women in business by connecting governments and the private sector to encourage, enable and embed women’s economic empowerment and women in leadership. Originating in May 2021, the Commonwealth Women’s Entrepreneurship Accelerator (CWEA) is a strategic multi-stakeholder partnership from the CBWN, the Global Entrepreneurship Network UK (GEN UK) and Oxentia. It is a direct response to three developments: the agreement by all Commonwealth Heads of Government in London in 2018 “to work towards an increase in the number and enhancement of the success rate of women-owned businesses, break down gender barriers in all sectors, and increase opportunities for women to trade internationally”; the recognition by the G20 in 2020 that “there is a missed opportunity – to tackle the gap that needs immediate action, which is the representation of women in emerging fields”; and the UN Global Acceleration Plan to advance gender equality by 2026 and its Action Coalitions on Economic Justice and Rights and Technology and Innovation launched in 2021.
The new partnership with CBWN in support of CWEA further solidifies WEA’s geographic scope of action across the 54 Commonwealth diverse country members in Africa, Asia, the Americas, Europe, and the Pacific, with 32 countries classified as “small states.” Small states are especially vulnerable to climate change and developmental challenges including gender inequalities.
Beyond scaling WEA and CBWN’s foundational areas of work, the partnership will also significantly focus on policy and advocacy to advance systemic change engaging Commonwealth member states and leveraging its networks of organizations and key stakeholders in support of women in business or aspiring women entrepreneurs in and across the Commonwealth.
“We know that multi-stakeholder partnerships and collective engagement is crucial to drive the change that women entrepreneurs need across sectors around the world,” said Deborah Gibbins, Chief Operating Officer of Mary Kay Inc. “WEA is thrilled to join forces with the Commonwealth Businesswomen’s Network and the Commonwealth Women’s Entrepreneurship Accelerator. Our collaboration will focus on augmenting, amplifying and accelerating impact. We’re more powerful together, and I look forward to our collective action journey in support of the SDGs.”
“The Commonwealth Businesswomen’s Network is delighted to partner with the United Nations Women’s Entrepreneurship Accelerator in this landmark initiative so we can unlock and unleash the power and potential for more women of diverse backgrounds,” said Freda Miriklis, Chair, Commonwealth Businesswomen’s Network. “Through this partnership, we’ll be able to more quickly harness our collective assets - for women, their communities and every girl that can and will be inspired by their stories.”
To learn more about the Women’s Entrepreneurship Accelerator, visit we-accelerate.com .
About the Women’s Entrepreneurship Accelerator
The Women’s Entrepreneurship Accelerator (WEA) is a multi-partnership initiative on women’s entrepreneurship convening 5 UN agencies, International Labour Organization (ILO), International Trade Centre (ITC), UN Global Compact (UNGC), UN Development Programme (UNDP), UN Women and Mary Kay Inc. to empower 5 million women entrepreneurs by 2030.
The ultimate goal of the initiative is to maximize the development impact of women entrepreneurship in achieving Sustainable Development Goals (SDGs) by creating an enabling ecosystem for women entrepreneurs around the world. The Accelerator exemplifies the transformational power of a multi-partnership of unique magnitude to harness the potential of women entrepreneurs.
Learn more at we-accelerate . Follow us: Twitter (@We_Accelerator ), Instagram (@we_accelerator ), Facebook (@womensentrepreneurshipaccelerator ), LinkedIn (@womensentrepreneurshipaccelerator )
About the Commonwealth Businesswomen’s Network
The Commonwealth Businesswomen’s Network (CBWN) works with women in business by connecting Governments and the private sector to encourage, enable and embed women’s economic empowerment. This is achieved through delivering activities, initiatives, products, and services focused on trade, talent, and training. It is the only accredited organisation focused on women’s economic empowerment and directly recognized by 54 governments across six continents. Learn more at www.cbwn.org
About the Commonwealth Women’s Entrepreneurship Accelerator
The Commonwealth Women’s Entrepreneurship Accelerator is a strategic multi stakeholder partnership on women’s entrepreneurship established as an outcome of the inaugural Commonwealth Women’s Entrepreneurship Summit (CWES) in May 2021, the first global event to focus on women in emerging tech sectors. CWES was convened by the Commonwealth Businesswomen’s Network; the Global Entrepreneurship Network; the UK Government (Women in Innovation Network, a programme of Innovation UK); and Africa’s largest network of women entrepreneurs (AWEP: African Women’s Entrepreneurship Program). The Commonwealth Women’s Entrepreneurship Accelerator is a partnership between the Commonwealth Businesswomen’s Network, Global Entrepreneurship Network-UK and Oxentia. Learn more at www.thecwea.org
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 58 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements, and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at marykayglobal.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20211027005291/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom